 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
James C. Tsai | |
|---|---|
 | |
| Born | 1963 |
| Education | Amherst College, Stanford University School of Medicine, Owen Graduate School of Management at Vanderbilt University |
| Medical career | |
| Profession | Ophthalmologist |
| Institutions | Vanderbilt University School of Medicine, Harkness Eye Institute at Columbia University College of Physicians and Surgeons, Yale University School of Medicine, New York Eye and Ear Infirmary of Mount Sinai, Icahn School of Medicine at Mount Sinai |
| Sub-specialties | Glaucoma and glaucoma surgery |
| Website | James C. Tsai at Mount Sinai |
James C. Tsai is a physician and scientist who serves as president of the New York Eye and Ear Infirmary of Mount Sinai.[1][2][3] He also serves as the Delafield-Rodgers Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai and chair of the department of ophthalmology at the Mount Sinai Health System.
Tsai published the first taxonomy of medication compliance and adherence barriers in patients with glaucoma, the initial paper describing the isolated-check visual evoked potential technology for patients with glaucoma,[4] and one of the first studies evaluating the use of erythropoietin for neuroprotection in an animal model of glaucoma.
- ^ "James C. Tsai Named President of New York Eye and Ear Infirmary of Mount Sinai". Retrieved September 25, 2017.
- ^ "Mount Sinai Launches Eye Research Institute". Retrieved 25 September 2017.
- ^ "Meet Our Doctors – The Advanced Center for Eyecare".
- ^ Kent, Christopher (15 October 2006). "icVEP: A New Way to Catch Early Glaucoma?". Review of Ophthalmology. Retrieved 25 September 2017.